ArticleThe pharmacogenomics journal2020

Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients.

Stephanie F Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.